trump glp 1 deal unveils to expand coverage and lower costs on obesity drugs Some Medicare recipients could soon

Eli Lilly CEO David Ricks announces details of the Medicare GLP-1 bridge program, offering weight loss medications like Fondeo and Zepbound for $50 per month to 20 million eligible Medicare Part D patients starting July 1.

Learn what they contain, what the science actually says, and what truly supports people using GLP-1 medications.

Whats the difference between metformin and Ozempic

WHO GLP-1 Treatments: The World Health Organization has issued new guidelines endorsing GLP-1 agonists as essential treatments for obesity, highlighting the urgent need for action against the rising global obesity epidemic affecting over one billion people and posing serious health risks.

Why It Is So Famous

Novo Nordisk research has explored how GLP-1 medications like Wegovy can quieten food noise, resulting in a healthier lifestyle, according to respondents.